Le Lézard
Classified in: Health
Subjects: NPT, HSP, ASI, BLK, NTA

Skin of Color Society Reaches New Heights as an International Organization Dedicated to Promoting Excellence in Skin of Color Dermatology


GENEVA, Ill., March 27, 2018 /PRNewswire-USNewswire/ -- The Skin of Color Society (SOCS), an international professional organization of physicians dedicated to promoting excellence in skin of color dermatology, reports record levels of organizational growth in terms of membership, mentorship, research, educational initiatives and media outreach. At its recent annual business meeting held in conjunction with the 2018 Annual Meeting of the American Academy of Dermatology, SOCS President Seemal R. Desai, MD, reviewed 2017-2018 highlights including:

Following the business meeting, the 14th SOCS Annual Scientific Symposium was presented, co-chaired and moderated by Drs. Andrew Alexis and Amy McMichael. Oral presentations were judged by: Drs. Roopal Kundu, Susan C. Taylor and Lynn McKinley-Grant. Six medical students / residents / research fellows presented their original research, including:

  1. Nahla Shihab, MD - Universitas Indonesia
  2. Yssra S. Soliman, BA - Albert Einstein College of Medicine
  3. Yemisi Dina, BS - Meharry Medical College
  4. Divya Seth - Harvard T.H. Chan School of Public Health
  5. Eseosa Asemota, MD, MPH - Tufts Medical Center
  6. Andrea Tovar Garza, MD - University of Texas Southwestern Medical Center

In addition, twenty-four medical students/residents/research fellows displayed research posters. A summary can be viewed by visiting: http://bit.ly/2p8FNeM

Five expert talks were presented during the SOCS Scientific Symposium by invited speakers, including:

  1. Amit G. Pandya, MD - University of Texas Southwestern Medical Center, "Pigmentary disorder breakthroughs                    
  2. Valerie D. Callender, MD - Callender Dermatology & Cosmetic Center, "Update on Hair Loss in Women of Color" 
  3. Hema Sundaram, MD - Dermatology, Cosmetic & Laser Surgery, "Emerging Strategies for Planning and Implementation of Aesthetic Treatments in Skin of Color"
  4. Steven L. Pruitt - Managing Partner, Watts Partners, "Raising the public policy profile and discussion on the treatment of skin scarring and keloids in patients with skin of color" 
  5. Jonathan Silverberg, MD - Northwestern University, "An update on atopic dermatitis including co-morbidities and treatment breakthroughs"

The SOCS leadership gratefully acknowledges contributions from the following 2017-2018 sponsors whose support helps to advance the SOCS mission: Leo Pharmaceuticals; Merz Aesthetics; Ortho Dermatologics; Pfizer; Sun Pharmaceuticals; Nutrafol/Nutraceutical Wellness; Procter & Gamble; Regeneron Healthcare Solutions; Aclaris Therapeutics, Inc; Dermira; Janssen Biotech, Inc; Global Vitiligo Foundation and many individual donors.

Numerous exciting initiatives are in the works for SOCS in 2018-2019. Visit: www.skinofcolorsociety.org

Contact: Kimberly Miller, Executive Director:  1-630-578-3991
[email protected] | www.skinofcolorsociety.org

SOURCE Skin of Color Society


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: